Antidepressant-like effect of n-3 PUFAs in CUMS rats: Role of tPA/PAI-1 system

Physiology and Behavior

Volumn 139, Issue , 2015, Pages 210-215

  Tang, Mimi ^a,b   Jiang, Pei ^a,b   Li, Huande ^a   Cai, Hualin ^a   Liu, Yiping ^a   Gong, Hui ^a   Zhang, Lihong ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Brain derived neurotrophic factor; Chronic unpredicted mild stress; Plasminogen activator inhibitor 1; Polyunsaturated fatty acids; Sertraline; Tissue plasminogen activator

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; OMEGA 3 FATTY ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERTRALINE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CHRONIC STRESS; CHRONIC UNPREDICTED MILD STRESS; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; HIPPOCAMPUS; MALE; NONHUMAN; PREFRONTAL CORTEX; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RAT; TREATMENT OUTCOME;

EID: 84919648228     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2014.11.054     Document Type: Article

References (31)

1. Brunoni A.R., Machado-Vieira R., Zarate C.A., Vieira E.L., Valiengo L., Bensenor I.M., et al. Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): An exploratory analysis. Prog Neuropsychopharmacol Biol Psychiatry 2014, 56C:91-96.
2. Bus B.A., Molendijk M.L., Tendolkar I., Penninx B.W., Prickaerts J., Elzinga B.M., et al. Chronic depression is associated with a pronounced decrease in serum brain-derived neurotrophic factor over time. Mol Psychiatry 2014, 26:83.
3. Cho K.S., Kwon K.J., Choi C.S., Jeon S.J., Kim K.C., Park J.H., et al. Valproic acid induces astrocyte-dependent neurite outgrowth from cultured rat primary cortical neuron via modulation of tPA/PAI-1 activity. Glia 2013, 61:694-709. [Epub 2013 Feb 4]. 10.1002/glia.22463.
4. Lu B., Pang P.T., Woo N.H. The yin and yang of neurotrophin action. Nat Rev Neurosci 2005, 6:603-614.
5. Ding Q., Ying Z., Gomez-Pinilla F. Exercise influences hippocampal plasticity by modulating brain-derived neurotrophic factor processing. Neuroscience 2011, 192:773-780. [Epub Jun 29]. 10.1016/j.neuroscience.2011.06.032.
6. Vines A., Delattre A.M., Lima M.M., Rodrigues L.S., Suchecki D., Machado R.B., et al. The role of 5-HT(1)A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism. Neuropharmacology 2012, 62:184-191. [Epub Jun 29]. 10.1016/j.neuropharm.2011.06.017.
7. Borsonelo E.C., Galduroz J.C. The role of polyunsaturated fatty acids (PUFAs) in development, aging and substance abuse disorders: review and propositions. Prostaglandins Leukot Essent Fatty Acids 2008, 78:237-245. [Epub May 27]. 10.1016/j.plefa.2008.03.005.
8. Appleton K.M., Rogers P.J., Ness A.R. Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 2010, 91:757-770. [Epub 2010 Feb 3]. 10.3945/ajcn.2009.28313.
9. Levant B., Ozias M.K., Davis P.F., Winter M., Russell K.L., Carlson S.E., et al. Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: interactions with reproductive status in female rats. Psychoneuroendocrinology 2008, 33:1279-1292. [Epub Aug 15]. 10.016/j.psyneuen.2008.06.012.
10. Wu A., Ying Z., Gomez-Pinilla F. Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 2008, 155:751-759. [Epub Jun 17]. 10.1016/j.neuroscience.2008.05.061.
11. Nobukata H., Ishikawa T., Obata M., Shibutani Y. Long-term administration of highly purified eicosapentaenoic acid ethyl ester prevents diabetes and abnormalities of blood coagulation in male WBN/Kob rats. Metabolism 2000, 49:912-919.
12. Din J.N., Archer R.M., Harding S.A., Sarma J., Lyall K., Flapan A.D., et al. Effect of omega-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in male cigarette smokers. Heart 2013, 99:168-174. [Epub 2012 Nov 26]. 10.1136/heartjnl-2012-302924.
13. Ferraz A.C., Kiss A., Araujo R.L., Salles H.M., Naliwaiko K., Pamplona J., et al. The antidepressant role of dietary long-chain polyunsaturated n-3 fatty acids in two phases in the developing brain. Prostaglandins Leukot Essent Fatty Acids 2008, 78:183-188. [Epub Apr 2]. 10.1016/j.plefa.2008.02.001.
14. Jiang P., Zhang W.Y., Li H.D., Cai H.L., Liu Y.P., Chen L.Y. Stress and vitamin D: altered vitamin D metabolism in both the hippocampus and myocardium of chronic unpredictable mild stress exposed rats. Psychoneuroendocrinology 2013, 38:2091-2098. [Epub Apr 20]. 10.1016/j.psyneuen.2013.03.017.
15. Park Y., Moon H.J., Kim S.H. N-3 polyunsaturated fatty acid consumption produces neurobiological effects associated with prevention of depression in rats after the forced swimming test. J Nutr Biochem 2012, 23:924-928. [Epub Aug 17]. 10.1016/j.jnutbio.2011.04.018.
16. Mahar I., Bambico F.R., Mechawar N., Nobrega J.N. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neurosci Biobehav Rev 2014, 38:173-192. [Epub Dec 1]. 10.1016/j.neubiorev.2013.11.009.
17. Bai M., Zhu X., Zhang Y., Zhang S., Zhang L., Xue L., et al. Abnormal hippocampal BDNF and miR-16 expression is associated with depression-like behaviors induced by stress during early life. PLoS One 2012, 7:e46921. [Epub 2012 Oct 8]. 10.1371/journal.pone.0046921.
18. Bahi A., Dreyer J.L. Hippocampus-specific deletion of tissue plasminogen activator "tPA" in adult mice impairs depression- and anxiety-like behaviors. Eur Neuropsychopharmacol 2012, 22:672-682. [Epub Feb 28]. 10.1016/j.euroneuro.2012.01.008.
19. Segawa M., Morinobu S., Matsumoto T., Fuchikami M., Yamawaki S. Electroconvulsive seizure, but not imipramine, rapidly up-regulates pro-BDNF and t-PA, leading to mature BDNF production, in the rat hippocampus. Int J Neuropsychopharmacol 2013, 16:339-350. [Epub 2012 Feb 6]. 10.1017/S1461145712000053.
20. Sartori C.R., Vieira A.S., Ferrari E.M., Langone F., Tongiorgi E., Parada C.A. The antidepressive effect of the physical exercise correlates with increased levels of mature BDNF, and proBDNF proteolytic cleavage-related genes, p11 and tPA. Neuroscience 2011, 180:9-18. [Epub Mar 1]. 10.1016/j.neuroscience.2011.02.055.
21. Tsai S.J., Hong C.J., Liou Y.J., Yu Y.W., Chen T.J. Plasminogen activator inhibitor-1 gene is associated with major depression and antidepressant treatment response. Pharmacogenet Genomics 2008, 18:869-875. 10.1097/FPC.0b013e328308bbc0.
22. Fang Y., Zhang L., Zeng Z., Lian Y., Jia Y., Zhu H., et al. Promoter polymorphisms of SERPINE1 are associated with the antidepressant response to depression in Alzheimer's disease. Neurosci Lett 2012, 516:217-220. [Epub Apr 5]. 10.1016/j.neulet.2012.03.090.
23. Eskandari F., Mistry S., Martinez P.E., Torvik S., Kotila C., Sebring N., et al. Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: implications for greater cardiovascular risk. Metabolism 2005, 54:918-924.
24. Lahlou-Laforet K., Alhenc-Gelas M., Pornin M., Bydlowski S., Seigneur E., Benetos A., et al. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease. Am J Cardiol 2006, 97:1287-1291. [Epub 2006 Mar 20].
25. Ge J.F., Gao W.C., Cheng W.M., Lu W.L., Tang J., Peng L., et al. Orcinol glucoside produces antidepressant effects by blocking the behavioural and neuronal deficits caused by chronic stress. Eur Neuropsychopharmacol 2014, 24:172-180. [Epub Jul 6]. 10.1016/j.euroneuro.2013.05.007.
26. Liu D., Xie K., Yang X., Gu J., Ge L., Wang X., et al. Resveratrol reverses the effects of chronic unpredictable mild stress on behavior, serum corticosterone levels and BDNF expression in rats. Behav Brain Res 2014, 264:9-16. [Epub Feb 4]. 10.1016/j.bbr.2014.01.039.
27. Wang H.N., Wang L., Zhang R.G., Chen Y.C., Liu L., Gao F., et al. Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: the role of the endocannabinoid system. J Psychiatr Res 2014, 51:79-87. [Epub Jan 17]. 10.1016/j.jpsychires.2014.01.004.
28. Zhou L., Xiong J., Lim Y., Ruan Y., Huang C., Zhu Y., et al. Upregulation of blood proBDNF and its receptors in major depression. J Affect Disord 2013, 150:776-784. [Epub Mar 26]. 10.1016/j.jad.2013.03.002.
29. Yoshida T., Ishikawa M., Niitsu T., Nakazato M., Watanabe H., Shiraishi T., et al. Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS One 2012, 7:e42676. [Epub 2012 Aug 3]. 10.1371/journal.pone.0042676.
30. Sierksma A.S., Vanmierlo T., De Vry J., Raijmakers M.E., Steinbusch H.W., van den Hove D.L., et al. Effects of prenatal stress exposure on soluble Abeta and brain-derived neurotrophic factor signaling in male and female APPswe/PS1dE9 mice. Neurochem Int 2012, 61:697-701. [Epub Jun 29]. 10.1016/j.neuint.2012.06.022.
31. Larsen M.H., Mikkelsen J.D., Hay-Schmidt A., Sandi C. Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment. J Psychiatr Res 2010, 44:808-816. [Epub Feb 20]. 10.1016/j.jpsychires.2010.01.005.